At a glance
- Originator Kyowa Hakko
- Class Antihypertensives
- Mechanism of Action Angiotensin receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Hypertension
Most Recent Events
- 26 May 2001 Discontinued-Preclinical for Hypertension in Japan (PO)
- 09 Jun 1997 No-Development-Reported for Hypertension in Japan (PO)
- 07 Apr 1995 New profile